Class information for:
Level 1: NO NSAIDS//NCX 4016//NO ASPIRIN

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
21370 421 40.2 85%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
343 3       NITRIC OXIDE//PEROXYNITRITE//NITRIC OXIDE SYNTHASE 36678
295 2             NITRIC OXIDE//PEROXYNITRITE//NITRIC OXIDE-BIOLOGY AND CHEMISTRY 18821
21370 1                   NO NSAIDS//NCX 4016//NO ASPIRIN 421

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 NO NSAIDS authKW 1065766 5% 64% 23
2 NCX 4016 authKW 777095 4% 71% 15
3 NO ASPIRIN authKW 721024 3% 76% 13
4 NITROASPIRIN authKW 534079 2% 82% 9
5 NO RELEASING ASPIRIN authKW 435178 1% 100% 6
6 NAPROXCINOD authKW 394881 2% 78% 7
7 PHOSPHO ASPIRIN authKW 362648 1% 100% 5
8 NITROFLURBIPROFEN authKW 355391 2% 70% 7
9 PHOSPHO SULINDAC authKW 326380 1% 75% 6
10 NITROPARACETAMOL authKW 302205 1% 83% 5

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Pharmacology & Pharmacy 2033 41% 0% 173
2 Chemistry, Medicinal 666 12% 0% 52
3 Gastroenterology & Hepatology 378 10% 0% 41
4 Oncology 133 11% 0% 47
5 Peripheral Vascular Diseases 70 5% 0% 19
6 Rheumatology 43 2% 0% 9
7 Physiology 32 4% 0% 17
8 Medicine, Research & Experimental 28 4% 0% 18
9 Cardiac & Cardiovascular System 23 4% 0% 18
10 Hematology 23 3% 0% 13

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 BRADER CANC 217589 1% 100% 3
2 CLIN GASTROENTEROL EPATOL 197043 3% 23% 12
3 SARAH C UPHAM GASTROENTEROL 163190 1% 75% 3
4 EXPT MED ENVIRONM BIOTECHNOL 145059 0% 100% 2
5 CANC PREVENT 81151 16% 2% 66
6 BIOCHEM PHARMA AB IMMUNOPHARMACOL 72530 0% 100% 1
7 BIOMED ELE ON PARAMAGNET SPECT IMAGING 72530 0% 100% 1
8 BIOQUIM CLIN FARM BIOQUIM 72530 0% 100% 1
9 CANC PREVENT DRUG DEV MED 72530 0% 100% 1
10 CANC PREVENTION 72530 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 BRITISH JOURNAL OF PHARMACOLOGY 2958 6% 0% 27
2 DIGESTIVE AND LIVER DISEASE 2210 2% 0% 9
3 JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 1642 5% 0% 22
4 EUROPEAN JOURNAL OF PHARMACOLOGY 1112 5% 0% 21
5 PHARMACOLOGICAL RESEARCH 866 2% 0% 7
6 NITRIC OXIDE-BIOLOGY AND CHEMISTRY 845 1% 0% 4
7 CARDIOVASCULAR DRUG REVIEWS 687 0% 0% 2
8 MOLECULAR CANCER THERAPEUTICS 632 1% 0% 6
9 EXPERT OPINION ON INVESTIGATIONAL DRUGS 534 1% 0% 4
10 JOURNAL OF MEDICINAL CHEMISTRY 468 3% 0% 12

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 NO NSAIDS 1065766 5% 64% 23 Search NO+NSAIDS Search NO+NSAIDS
2 NCX 4016 777095 4% 71% 15 Search NCX+4016 Search NCX+4016
3 NO ASPIRIN 721024 3% 76% 13 Search NO+ASPIRIN Search NO+ASPIRIN
4 NITROASPIRIN 534079 2% 82% 9 Search NITROASPIRIN Search NITROASPIRIN
5 NO RELEASING ASPIRIN 435178 1% 100% 6 Search NO+RELEASING+ASPIRIN Search NO+RELEASING+ASPIRIN
6 NAPROXCINOD 394881 2% 78% 7 Search NAPROXCINOD Search NAPROXCINOD
7 PHOSPHO ASPIRIN 362648 1% 100% 5 Search PHOSPHO+ASPIRIN Search PHOSPHO+ASPIRIN
8 NITROFLURBIPROFEN 355391 2% 70% 7 Search NITROFLURBIPROFEN Search NITROFLURBIPROFEN
9 PHOSPHO SULINDAC 326380 1% 75% 6 Search PHOSPHO+SULINDAC Search PHOSPHO+SULINDAC
10 NITROPARACETAMOL 302205 1% 83% 5 Search NITROPARACETAMOL Search NITROPARACETAMOL

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 BOLLA, M , ALMIRANTE, N , BENEDINI, F , (2005) THERAPEUTIC POTENTIAL OF NITRATE ESTERS OF COMMONLY USED DRUGS.CURRENT TOPICS IN MEDICINAL CHEMISTRY. VOL. 5. ISSUE 7. P. 707 -720 61 72% 20
2 RIGAS, B , WILLIAMS, JL , (2008) NO-DONATING NSAIDS AND CANCER: AN OVERVIEW WITH A NOTE ON WHETHER NO IS REQUIRED FOR THEIR ACTION.NITRIC OXIDE-BIOLOGY AND CHEMISTRY. VOL. 19. ISSUE 2. P. 199-204 34 68% 33
3 KEEBLE, JE , MOORE, PK , (2002) PHARMACOLOGY AND POTENTIAL THERAPEUTIC APPLICATIONS OF NITRIC OXIDE-RELEASING NON-STEROIDAL ANTI-INFLAMMATORY AND RELATED NITRIC OXIDE-DONATING DRUGS.BRITISH JOURNAL OF PHARMACOLOGY. VOL. 137. ISSUE 3. P. 295 -310 52 46% 120
4 GRESELE, P , MOMI, S , (2006) PHARMACOLOGIC PROFILE AND THERAPEUTIC POTENTIAL OF NCX 4016, A NITRIC OXIDE-RELEASING ASPIRIN, FOR CARDIOVASCULAR DISORDERS.CARDIOVASCULAR DRUG REVIEWS. VOL. 24. ISSUE 2. P. 148-168 42 51% 24
5 BOLLA, M , MOMI, S , GRESELE, P , DEL SOLDATO, P , (2006) NITRIC OXIDE-DONATING ASPIRIN (NCX 4016): AN OVERVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND CLINICAL PERSPECTIVES.EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. VOL. 62. ISSUE . P. 145 -154 41 51% 18
6 RIGAS, B , (2007) THE USE OF NITRIC OXIDE-DONATING NONSTEROIDAL ANTI-INFLAMMATORY DRUGS IN THE CHEMOPREVENTION OF COLORECTAL NEOPLASIA.CURRENT OPINION IN GASTROENTEROLOGY. VOL. 23. ISSUE 1. P. 55-59 17 89% 23
7 KODELA, R , CHATTOPADHYAY, M , NATH, N , CIECIURA, LZ , POSPISHILL, L , BORING, D , CROWELL, JA , KASHFI, K , (2011) SYNTHESIS AND BIOLOGICAL ACTIVITY OF ACETYL-PROTECTED HYDROXYBENZYL DIETHYL PHOSPHATES (EHBP) AS POTENTIAL CHEMOTHERAPEUTIC AGENTS.BIOORGANIC & MEDICINAL CHEMISTRY LETTERS. VOL. 21. ISSUE 23. P. 7146-7150 16 73% 1
8 FIORUCCI, S , SANTUCCI, L , GRESELE, P , FACCINO, RM , DEL SOLDATO, P , MORELLI, A , (2003) GASTROINTESTINAL SAFETY OF NO-ASPIRIN (NCX-4016) IN HEALTHY HUMAN VOLUNTEERS: A PROOF OF CONCEPT ENDOSCOPIC STUDY.GASTROENTEROLOGY. VOL. 124. ISSUE 3. P. 600-607 19 63% 133
9 BURGAUD, JL , RIFFAUD, JP , DEL SOLDATO, P , (2002) NITRIC-OXIDE RELEASING MOLECULES: A NEW CLASS OF DRUGS WITH SEVERAL MAJOR INDICATIONS.CURRENT PHARMACEUTICAL DESIGN. VOL. 8. ISSUE 3. P. 201 -213 27 47% 64
10 FIORUCCI, S , DEL SOLDATO, P , (2003) NO-ASPIRIN: MECHANISM OF ACTION AND GASTROINTESTINAL SAFETY.DIGESTIVE AND LIVER DISEASE. VOL. 35. ISSUE . P. S9-S19 24 52% 38

Classes with closest relation at Level 1


Rank Class id link
1 13857 DIAZENIUMDIOLATE//JS K//COMPARAT CARCINOGENESIS
2 13198 PRODRUG//DIFFUSION CELL EXPERIMENTS//DERMAL PRODRUG
3 4143 GASTRIC ULCER//GASTROPROTECTION//GASTROPROTECTIVE
4 11362 COXIBS//SOLUMATRIX//ROFECOXIB
5 7175 NITRIC OXIDE//INOS//RADIAT BIOL BRANCH
6 32039 GLAXO HERITAGE ASTHMA//2K 1C RAT//AUTONOMIC NITRERGIC NERVES
7 2243 CYCLOOXYGENASE//PROSTAGLANDIN H SYNTHASE//AB HANCOCK JR MEM CANC
8 1326 NSAIDS//NON STEROIDAL ANTI INFLAMMATORY DRUGS//LOW DOSE ASPIRIN
9 12740 DIAPHRAGM DISEASE//SMALL INTESTINAL INJURY//SMALL INTESTINAL ULCER
10 22705 CELL PHYSIOL MOL IMAGE//ANESTHET TOXICOL//CELL BIOL MOL IMAGE

Go to start page